Placebo effect in canine epilepsy trials

Journal of Veterinary Internal Medicine

Volumn 24, Issue 1, 2010, Pages 166-170

  Munana K R ^a   Zhang, D ^a   Patterson, E E ^b  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Clinical trials; Dog; Epilepsy; Statistical modeling

Indexed keywords

ANTICONVULSIVE AGENT; BROMIDE; PHENOBARBITAL; POTASSIUM BROMIDE; POTASSIUM DERIVATIVE;

ANIMAL; ANIMAL DISEASE; ARTICLE; DIET; DIET THERAPY; DOG; DOG DISEASE; EPILEPSY; META ANALYSIS; PLACEBO EFFECT; STATISTICAL MODEL;

ANIMALS; ANTICONVULSANTS; BROMIDES; DIET; DOG DISEASES; DOGS; EPILEPSY; LINEAR MODELS; PHENOBARBITAL; PLACEBO EFFECT; POTASSIUM COMPOUNDS;

ANIMALIA; CANIS FAMILIARIS;

EID: 73349107805     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2009.0407.x     Document Type: Article

References (17)

1. McMillan FD. The placebo effect in animals. J Am Vet Med Assoc 1999;215:992-999.
2. Benson H, Friedman R. Harnessing the power of the placebo effect and renaming it remembered wellness. Annu Rev Med 1996;47:193-199.
3. Beecher HK. The powerful placebo. J Am Med Assoc 1955;159:1602-1606.
4. Roberts AH, Kewman DG, Mercier L, Hovell M. The power of nonspecific effects in healing: Implication for psychosocial and biological treatments. Clin Psychol Rev 1993;13:375-391.
5. Jæger GT, Larsen S, Moe L. Stratification, blinding and placebo effect in a randomized, double blind placebo-controlled clinical trial of gold bead implantation in dogs with hip dysplasia. Acta Vet Scand 2005;46:57-68.
6. Muñana KR, Vitek SM, Tarver WB, et al. Use of vagal nerve stimulation as a treatment for refractory epilepsy in dogs. J Am Vet Med Assoc 2002;221:977-983.
7. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-130.
8. Burneo JG, Montori VM, Faught E. Magnitude of the placebo effect in randomized trials of antiepileptic agents. Epilepsy Behav 2002;3:532-534.
9. Cramer JA, Fisher R, Ben-Menachem E, et al. New antiepileptic drugs: Comparison of key clinical trials. Epilepsia 1999;40:590-600.
10. Ernst E. Placebo: New insights into an old enigma. Drug Discov Today 2007;12:413-418.
11. Morton V, Torgerson DJ. Regression to the mean: Treatment effect without the intervention. J Eval Clin Pract 2005;11:59-65.
12. Hróbjartsson A, Gøtzsche P. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 2001;344:1594-1602.
13. Platt SR, Adams V, Garosi LS, et al. Treatment with gabapentin of 11 dogs with refractory idiopathic epilepsy. Vet Rec 2006;159:881-884.
14. Govendir M, Perkins M, Malik R. Improving seizure control in dogs with refractory epilepsy using gabapentin as an adjunctive agent. Aus Vet J 2005;83:602-608.
15. Dewey CW, Guiliano R, Boothe DM, et al. Zonisamide therapy for refractory idiopathic epilepsy in dogs. J Am Anim Hosp Assoc 2004;40:285-291.
16. von Klopmann T, Rambeck B, Tipold A. Prospective study of zonisamide therapy for refractory idiopathic epilepsy in dogs. J Sm Anim Pract 2007;48:134-138.
17. Volk HA, Matiasek LA, Luján Feliu-Pascual A, et al. The efficacy and tolerability of levetiracetam in pharmacoresistant epileptic dogs. Vet J 2008;176:310-319.